Results 41 to 50 of about 6,765 (189)

Telangiectasia hemorrágica hereditária: uma causa rara de anemia grave Hereditary hemorrhagic telangiectasia: a rare cause of severe anemia

Jornal Brasileiro de Pneumologia, 2007
Telangiectasia hemorrágica hereditária é uma doença autossômica dominante na qual comunicações arteriovenosas afetam comumente pele, superfícies mucosas, pulmões, cérebro e trato gastrointestinal.
José Wellington Alves dos Santos, Tiago Chagas Dalcin, Kelly Ribeiro Neves, Keli Cristina Mann, Gustavo Luis Nunes Pretto, Alessandra Naimaier Bertolazi   +5 more
doaj   +1 more source

Hereditary hemorrhagic telangiectasia [PDF]

Canadian Medical Association Journal, 2009
Hereditary hemorrhagic telangiectasia, or Osler–Weber–Rendu syndrome, is an autosomal dominant vascular disorder that affects multiple systems. It is characterized by skin and mucosal telangiectasias and arteriovenous malformations. In 1876, Sir John Legg described a case of “hemophilia”
openaire   +2 more sources

Angiogenesis, hereditary hemorrhagic telangiectasia and COVID-19

, 2020
Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal-dominant disease characterized by pathologic angiogenesis that provokes vascular overgrowth.
López-Wolf, Daniel, Riera-Mestre, Antoni, Moreno, Manuela, Del Castillo, Raul, Iriarte, Adriana   +4 more
core   +1 more source

Mobile Mitral and Aortic Valvular Masses in Patients With Hereditary Hemorrhagic Telangiectasia Receiving Intravenous Bevacizumab

Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 2020
Bevacizumab is now an emerging treatment option for severe hereditary hemorrhagic telangiectasia–related bleeding including epistaxis and gastrointestinal tract bleeding.
Hasan Ahmad Albitar, MD, Yahya Almodallal, MBBS, Rick Nishimura, MD, Vivek N. Iyer, MD, MPH   +3 more
doaj   +1 more source

Hereditary Hemorrhagic Telangiectasia: Diagnosis and Management

, 2022
Hereditary hemorrhagic telangiectasia (HHT), or Rendu-Osler-Weber syndrome, is a dominantly inheritable rare disease with a prevalence of 1:5000–10,000 inhabitants [...
Cuesta M. Angel, Angel Cuesta, Angel, Cuesta M.   +2 more
core   +1 more source

EHA Endorsement of the Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. [PDF]

, 2021
Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu disease, is a relatively common “rare” vascular disease with an estimated prevalence of 1 in 5000–8000.1,2 Inheritance is autosomal dominant.
Iris Baumgartner, Rössler, Jochen Karl, Baumgartner, Iris, Johanna A. Kremer Hovinga, Jochen Rössler, Rößler, Jochen, Kremer Hovinga, Johanna A.   +6 more
core   +1 more source

Stroke in hereditary hemorrhagic telangiectasia patients. New evidence for repeated screening and early treatment of pulmonary vascular malformations: two case reports

BMC Neurology, 2011
Background Paradoxical embolism due to pulmonary arteriovenous malformations is the main mechanism of brain infarction in patients with hereditary hemorrhagic telangiectasia.
Viader Fausto, Babin Emmanuel, Cogez Julien, Ribeiro Espartaco, Defer Gilles   +4 more
doaj   +1 more source

Malformações arteriovenosas pulmonares – Associação a telangiectasia hemorrágica hereditária. Casos clínicos e rastreio familiar

Revista Portuguesa de Pneumologia, 2006
Resumo: As malformações arteriovenosas pulmonares são raras e mais de metade dos casos surgem em associação a telangiectasia hemorrágica hereditária.Faz-se uma revisão teórica sobre a apresentação clínica, abordagem diagnóstica, terapêutica
Diva Ferreira, Joana Amado, Raquel Duarte, José Almeida, Paulo Morgado, Teresa Shiang   +5 more
doaj   +1 more source

A rare clinical case of the patient with pulmonary hypertension associated with hereditary hemorrhagic telangiectasia. Case report [PDF]

Терапевтический архив, 2022
The article describes a rare clinical case of the patient with pulmonary hypertension associated with hereditary hemorrhagic telangiectasia and discusses the issues of the treatment choice of these patients.
Anna M. Kasparova, Zarina S. Valieva, Tamila V. Martynyuk   +2 more
doaj   +1 more source

Low-dose bevacizumab did not reduce epistaxis in patient with hereditary hemorrhagic telangiectasia : a case report [PDF]

, 2020
A 74-year-old man with refractory epistaxis and melena was diagnosed with hereditary hemorrhagic telangiectasia （HHT）. Frequent epistaxis required gauze packing, electrocautery, and blood transfusion. Ileocecal resection did not reduce melena. To control
Ogawa, Hiroshi, Yamauchi, Tomohiko, Tsunoda, Saburo, Yokoyama, Shuji, Utano, Kenichi   +4 more
core